4.4 Editorial Material

Adult-onset Still's disease following COVID-19 vaccination

Journal

LANCET RHEUMATOLOGY
Volume 3, Issue 10, Pages E678-E680

Publisher

ELSEVIER
DOI: 10.1016/S2665-9913(21)00218-6

Keywords

-

Categories

Funding

  1. AbbVie
  2. Amgen
  3. Celgene
  4. Eli Lilly
  5. Novartis
  6. Pfizer

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available